The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 375.00
Bid: 370.00
Ask: 380.00
Change: 13.00 (3.59%)
Spread: 10.00 (2.703%)
Open: 375.00
High: 375.00
Low: 375.00
Prev. Close: 362.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

Thu, 09th Apr 2020 14:54

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Thursday and not separately reported by Alliance News:

----------

Naked Wines PLC - wine retailer - Sales boosted since social restriction measures introduced, particularly in US. Expects revenue in year ended March to be in excess of GBP200 million, ahead of market consensus of GBP198.9 million.

----------

Distil PLC - premium rum, gin and vodka brands - Volumes up 80% and revenue up 97% in January to March, Distil's financial fourth quarter. Expects full-year performance to be in line with market expectations. Seeing sales boost from consumers stocking up on alcohol during Covid-19 lockdowns but too early to forecast market trends over next six months.

----------

Volvere PLC - Shire Foods frozen pastry - Expects to report revenue from continuing operations of GBP23 million for 2019, up from GBP18.3 million in 2018, and breakeven from the same at the pretax level, unchanged from the underlying result in 2018. As a food maker, Shire has "an important part to play during the current Covid-19 pandemic". Uplift in sales to retail customers in first quarter of 2020, but downturn in orders from foodservice customers, so "too early to say whether this will be sustained and ultimately translate into higher sales for the group for the year overall".

----------

Warpaint London PLC - cosmetics - Reports "substantial reduction" in sales due to lockdown measures forcing retail outlets to close, but operating online. Furloughs 84 out of 115 UK staff, about 73% and suspends marketing spend. Won't recommend final dividend for 2019.

----------

DP Aircraft I Ltd - aircraft leasing - Says Thai Airways has asked for temporary relief on its lease payment obligations. Has begun discussions about this. Says Thai remains fully committed to its obligations and has made all payments due to date. DP Aircraft I will speak to its lending banks about the situation as well.

----------

Cora Gold Ltd - miner - Suspended drill programme at Foulbe permit, Senegal, following government advice. Says field work continues in Sanankoro project, Mali.

----------

Resolute Mining Ltd - gold miner - Donates USD1 million to African governments to support Covid-19 response.

----------

Anglo Pacific Group PLC - natural resources - Says travel curbs mean annual general meeting pushed back to May 27. Final dividend of 4.125 pence to be paid later as a result.

----------

Eurasia Mining PLC - gold producer - Aiming to keep cash position at GBP600,000 to ensure it does not to use credit line, even if Covid-19 disrupts trading. Shares remain suspended pending clarification of relationship with CITIC Group Corp Ltd.

----------

Dukemount Capital PLC - property firm - Says West Derby project still on track for August completion, despite Covid-19.

----------

Warehouse REIT PLC - real estate investment trust - Says 74% of rent for June quarter received, rises to 82% when including tenants paying monthly. Committed to meeting 6.2p per share target dividend.

----------

Hibernia REIT PLC - real estate investment trust - Work on development sites in Ireland suspended in line with government guidance. Says too early to have full visibility on virus impact. Secures three new lettings in quarter to March 31, boosting annual rent by EUR3.3 million.

----------

Town Centre Securities PLC - property investor - Receives 71% of rent due for April, agrees to defer payments for a further 15%. Furloughes staff across car park, hotel and property businesses and board taking a 20% salary reduction. Suspends all financial guidance and making decision about 3.25p interim payout.

----------

Livermore Investments Group Ltd - investor - Says virus spread and US government response changing demand patterns. Expects reduced earnings from borrowers in its collateralized loan obligation portfolio.

----------

Alpha Financial Markets Consulting PLC - lending services provider - Expects results for year ended March 31 to be in line with market expectations. Says Covid-19 has had almost no effect on trading so far but expects impact on new business later. Chief executive, chief financial officer and non-executives have taken a 40% pay cut.

----------

Eckoh PLC - payment technology - Says sales pipeline strong but Covid-19 has caused delays. Halts new hiring, postpones salary increases and will not propose final dividend unless market conditions improve. Expects double-digit revenue growth from US and UK divisions in year ended March 31.

----------

IMImobile PLC - cloud communications - Forecasts 17% revenue jump in year ended March 3. Says little Covid-19 impact so far but cutting costs and freezing hiring as a precaution. Some UK employees furloughed and board members take 33% pay cut. Raises GBP22.2 million in placing of 7.4 million shares at 300p each.

----------

Location Sciences Group PLC - location data provider - Says customers in retail and leisure sectors most affected by UK lockdown measures. Predicts second quarter revenue to be lower than expected. Cuts marketing spend and notes a long-standing shareholder died from the virus.

----------

ProPhotonix Ltd - LED lighting systems - Says no virus impact on first three months of 2020 but future hit "inevitable". Some customers in March ceased operations. Non-essential operating costs have been cut, and CEO takes 50% salary reduction.

----------

Van Elle Holdings PLC - engineering - Proposes equity raise of GBP6.7 million to ensure "sufficient headroom" to mitigate Covid-19 impact. Company placing 26.7 million shares at 25p each.

----------

Pressure Technologies PLC - engineering - Says both Chesterfield Special Cylinders and Precision Machined Components experience disruption due to virus, though all sites remain open. Withdraws full-year guidance

----------

Avingtrans PLC - engineering - Cancels interim dividend, to cut business costs, defer non-critical capital expendituren and use government stimulus measures in UK and US. Says 20% of UK employees furloughed. Board members take 20% salary reduction.

----------

TClarke PLC - building services - Postpones annual general meeting due to travel restrictions. To issue revised date soon. Final dividend postponed as it needs shareholder approval

----------

Speedy Hire PLC - tools and equipment hiring - Says Covid-19 reduces activity levels and lessens demand. Furloughs roughly 50% of employees and halts hiring. Leadership team and board take 20% pay cut and considering whether to pay final dividend.

----------

Rotala PLC - bus operator - Says no final dividend to be proposed but mulling special interim dividend. To furlough staff under UK Coronavirus job retention scheme. Withdraws full-year guidance.

----------

Gama Aviation PLC - aviation services - Says all divisions operational but some activity reduced. Using paycheck protection programme in US and furloughing "small number" of staff in UK. Suspends guidance for 2020. To publish 2019 annual report by end of July due to Covid-19 disruption. Will apply to AIM for extension beyond June 30 deadline.

----------

Silence Therapeutics PLC - RNA therapies - Will repurpose Berlin site to produce parts for Covid-19 diagnostics tests. Performing the work on a cost-only basis for Berlin-based TIB Molbiol GmbH.

----------

Advanced Oncotherapy PLC - cancer treatment - Says Covid-19 lockdowns in UK means timetabled LIGHT cancer treatments delayed. First patient to be treated in 2021 and not 2020 as first planned. Plans to raise GBP14.9 million from issue of 59.6 million shares at 25p each.

----------

MaxCyte Inc - cell-based therapies - "Unprecedented" movement curbs amid Covid-19 could hurt revenue. Fourth set of patients dosed in CARMA trial of MCY-M11 cell-based therapy for ovarian cancer.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 Mar 2023 09:32

MaxCyte flags 2022 revenue growth, sets new guidance

(Sharecast News) - Cell engineering technology company MaxCyte said in an update on Tuesday that it was expecting full-year 2022 total revenue of $44.3m, which would represent growth of 31% over 2021.

Read more
30 Jan 2023 16:23

TRADING UPDATES: DP Eurasia annual sales grow despite Russia decline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
4 Jan 2023 08:56

MaxCyte signs strategic platform licence with Catamaran Bio

(Alliance News) - MaxCyte Inc on Wednesday said it signed a strategic platform licence with biotechnology company Catamaran Bio Inc.

Read more
4 Jan 2023 07:45

MaxCyte signs strategic platform licence with Catamaran Bio

(Sharecast News) - Commercial cell engineering company MaxCyte announced the signing of a strategic platform licence (SPL) with Catamaran Bio on Wednesday.

Read more
5 Dec 2022 21:49

TRADING UPDATES: MaxCyte in deal; Angus to resume Saltfleetby drilling

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2022 13:28

MaxCyte inks deal with South Korea's Curamys

(Sharecast News) - Cell engineering technology company MaxCyte announced a strategic platform licence with South Korea-based biotechnology specialist Curamys on Monday, which develops cell and gene therapies using cell fusion technology to treat rare intractable diseases, including Duchenne muscular dystrophy and amyotrophic lateral sclerosis.

Read more
10 Nov 2022 13:06

MaxCyte revenues improve in third quarter

(Sharecast News) - Cell engineering technology specialist MaxCyte reported total third-quarter revenue of $10.6m on Thursday, making for an increase of 5% year-on-year.

Read more
2 Nov 2022 15:43

UK earnings, trading statements calendar - next 7 days

Thursday 3 November 
BT Group PLCHalf Year Results
Gattaca PLCFull Year Results
Glanbia PLCQ3 Results
Helios Towers PLCQ3 Results
Hikma Pharmaceuticals PLCTrading Statement
Howden Joinery Group PLCTrading Statement
J Sainsbury PLCHalf Year Results
Lancashire Holdings LtdTrading Statement
OSB Group PLCTrading Statement
Polymetal International PLCQ3 Results
RS Group PLCHalf Year Results
Rolls-Royce Holdings PLCTrading Statement
Smith & Nephew PLCTrading Statement
TI Fluid Systems PLCTrading Statement
Trainline PLCHalf Year Results
UP Global Sourcing Holdings PLCFull Year Results
WAG Payment Solutions PLCTrading Statement
Wheaton Precious Metals CorpQ3 Results
Woolworths Group LtdQ1 Results
Friday 4 November 
Apax Global Alpha LtdFull Year Results
Monday 7 November 
Great Eastern Energy Corp LtdHalf Year Results
Kingspan Group PLCTrading Statement
Ryanair Holdings PLCHalf Year Results
Tuesday 8 November 
Argentex Group PLCHalf Year Results
Associated British Foods PLCFull Year Results
Aveva Group PLCHalf Year Results
Beximco Pharmaceuticals LtdFull Year Results
Coca-Cola HBC AGTrading Statement
DCC PLCHalf Year Results
Direct Line Insurance Group PLCTrading Statement
Egdon Resources PLCFull Year Results
Hilton Food Group PLCTrading Statement
Marks Electrical Group PLCHalf Year Results
Oxford Instruments PLCHalf Year Results
Persimmon PLCTrading Statement
Warehouse REIT PLCHalf Year Results
YouGov PLCFull Year Results
Zoo Digital Group PLCHalf Year Results
Wednesday 9 November 
Aviva PLCTrading Statement
Biffa PLCHalf Year Results
Conduit Holdings LtdTrading Statement
Dignity PLCTrading Statement
Flutter Entertainment PLCTrading Statement
Gelion PLCFull Year Results
Georgia Capital PLCQ3 Results
Gym Group PLCTrading Statement
JD Wetherspoon PLCTrading Statement
ITV PLCTrading Statement
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Norcros PLCHalf Year Results
Picton Property Income LtdHalf Year Results
Smiths News PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Tracsis PLCFull Year Results
Volex PLCHalf Year Results
Watches of Switzerland Group PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Sep 2022 21:38

TRADING UPDATES: LoopUp, Surface raise capital; MaxCyte wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
11 Aug 2022 14:31

MaxCyte hikes guidance after solid first half

(Sharecast News) - Cell engineering company MaxCyte reported total first-half revenue of $21.2m on Thursday, up 56% year-on-year, as it increased its guidance for the full year.

Read more
10 Aug 2022 22:01

IN BRIEF: MaxCyte grows revenue but widens loss in second quarter

MaxCyte Inc - Gaithersburg, Maryland-based platform for cell-based research - Says second quarter revenue grew 35% year-on-year to USD9.6 million from USD7.1 million, "driven by strong growth in the cell therapy market; core business revenues grew 45% led by revenue from cell therapy customers which increased 61%, with drug discovery revenues growing by 4%", the firm says. Net loss for the quarter widens to USD8.3 million from US4.4 million. For the first half as a whole, revenue rises 56% year-on-year to USD21.2 million from USD13.6 million, as net loss widens slightly to USD12.3 million from USD11.5 million. Expects core business revenue in full year to grow approximately 30%. Continues to expect SPL Program-related revenue to be around USD4 million for the year. Says is making investments to drive revenue growth, and expand applications for its technology.

Read more
3 Aug 2022 15:57

UK earnings, trading statements calendar - next 7 days

Thursday 4 August 
  
Centamin PLCHalf Year Results
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Informa PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Friday 5 August 
FBD Holdings PLCHalf Year Results
Hargreaves Lansdown PLCFull Year Results
London Stock Exchange Group PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewables Infrastructure Group LtdHalf Year Results
WPP PLCHalf Year Results
Monday 8 August 
Clarkson PLCHalf Year Results
Diversified Energy Company PLCHalf Year Results
Gran Tierra Energy IncQ2 Results
Griffin Mining LtdHalf Year Results
ITM Power PLCFull Year Results
Kosmos Energy LtdQ2 Results
PageGroup PLCHalf Year Results
RM Infrastructure Income PLCHalf Year Results
Tuesday 9 August 
abrdn PLCHalf Year Results
Bellway PLCTrading Statement
Blue Planet Investment Trust PLCFull Year Results
Burford Capital LtdHalf Year Results
Clarkson PLCHalf Year Results
H&T Group PLCHalf Year Results
InterContinental Hotels Group PLCHalf Year Results
IWG PLCHalf Year Results
Just Group PLCHalf Year Results
Legal & General Group PLCHalf Year Results
Quarto Group IncHalf Year Results
RPS Group PLCHalf Year Results
SIG PLCHalf Year Results
TI Fluid Systems PLCHalf Year Results
Zotefoams PLCHalf Year Results
Wednesday 10 August 
4imprint Group PLCHalf Year Results
Aberdeen New India Investment Trust PLCFull Year Results
Admiral Group PLCHalf Year Results
Arix Bioscience PLCHalf Year Results
Atalaya Mining PLCHalf Year Results
Avast PLCHalf Year Results
Aviva PLCHalf Year Results
Baillie Gifford US Growth Trust PLCFull Year Results
BlackRock Energy & Resources Income Trust PLCHalf Year Results
CLS Holdings PLCHalf Year Results
Computacenter PLCTrading Statement
ContourGlobal PLCHalf Year Results
Deliveroo PLCHalf Year Results
Goodwin PLCFull Year Results
Henderson Smaller Cos Investment Trust PLCFull Year Results
Hostelworld Group PLCHalf Year Results
HydrogenOne Capital Growth PLCHalf Year Results
MaxCyte IncQ2 Results
Provident Financial PLCHalf Year Results
Prudential PLCHalf Year Results
Quilter PLCHalf Year Results
S&U PLCTrading Statement
TP ICAP Group PLCHalf Year Results
UK Commercial Property REIT LtdTrading Statement
Videndum PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 Jul 2022 14:05

IN BRIEF: MaxCyte enters strategic platform license agreement with LG

MaxCyte Inc - Gaithersburg, Maryland-based platform for cell-based research - Signs a strategic platform license agreement with Korean chemical company LG Chem Ltd, a subsidiary of LG Corp. Explains that the deal gives LG non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform. MaxCyte will receive platform licensing fees and programme related revenue.

Read more
22 Jun 2022 15:48

UK shareholder meetings calendar - next 7 days

Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
Wednesday 29 June 
Africa Opportunity Fund LtdAGM
Argo Blockchain PLCAGM
Atome Energy PLCAGM
Brave Bison Group PLCAGM
Concurrent Technologies PLCAGM
Eden Research PLCAGM
Facilities by ADF PLCAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Hurricane Energy PLCAGM
i(x) Net Zero PLCAGM
Lords Group Trading PLCAGM
MaxCyte IncAGM
Meggitt PLCAGM
Mobile Tornado Group PLCAGM
NB Distressed Debt Investment Fund LtdAGM
NetScientific PLCAGM
Provident Financial PLCAGM
RA International Group PLCAGM
Reabold Resources PLCAGM
Symphony Environmental Technologies PLCAGM
Team17 Group PLCAGM
ThinkSmart LtdGM re approval for capital return
Trinity Exploration & Production PLCAGM
URA Holdings PLCAGM
XP Factory PLCAGM
Zaim Credit Systems PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
10 May 2022 12:01

IN BRIEF: MaxCyte first-quarter loss narrows; raises annual guidance

MaxCyte Inc - Gaithersburg, Maryland-based platform for cell-based research - Says is pleased with positive start to 2022 with "very strong" first-quarter results. For three months to March 31, posts net loss USD4.1 million, narrowed from USD7.1 million last year on revenue of USD11.6 million, up 78% from USD6.5 million. Generates total of USD2.0 million in Strategic Platform License program-related revenue in the first quarter of 2022, compared to immaterial SPL program-related revenue in the first quarter of 2021. For 2022, expects core business revenue to grow at least 25% compared to 2021 core business revenue. It also continues to expect SPL program-related revenue to be around USD4 million in 2022.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.